Chris Gent

From Wikipedia, the free encyclopedia

Sir Christopher Gent (Beckenham, Kent, May 10, 1948) is the former chief executive officer of Vodafone, a British cell-phone company. After retiring in July 2003, he was awarded the honorary title of Company's President for Life on his departure as a mark of his achievement in developing the company, till his resignation from that position in March 2006. The title carried no salary, nor any advisory responsibilities, but was a symbolic link to the business that few former chief executives are allowed to retain.

Gent, widely credited with transforming Vodafone from a small British company into a global giant, and who engineered Vodafone's 178 billion euro ($212 billion) historic purchase of Germany's Mannesmann in 2000.

He is now Chairman of GlaxoSmithKline, a British pharmaceutical company.

From October 2005 to October 2006 he served on the Tax Reform Commission, established by the Shadow Chancellor of the Exchequer, George Osborne MP.

In March 2007 Gent called for a referendum on London's hosting of the 2012 Olympics. He was quoted as saying "I cannot see that the long-term economic benefit of hosting the Games outweighs the costs and the horrific burden on the taxpayer, particularly London rate-payers. The cost for them is going to be astronomically high."

[edit] Quotes

"These are excellent results." — Chris Gent in reference to a Vodafone annual report which included a record US $19.8 billion loss (year unknown).

GlaxoSmithKline plc

Corporate Directors: Lawrence Culp | Crispin Davis | Jean-Pierre Garnier | Chris Gent | Julian Heslop | Deryck Maughan | Ian Prosser | Ronaldo Schmitz | Lucy Shapiro | Robert Wilson | Tadataka Yamada

Products: Bupropion (Zyban) | Co-amoxiclav (Augmentin) | Paroxetine (Paxil, Seroxat, Aropax) | Rosiglitazone (Avandia)

Annual Revenue: $39.0 billion USD (2% FY 2004) | Employees: 100,019 | Stock Symbol: LSE: GSK NYSE: GSK | Website: www.gsk.com

In other languages